Shares of Veren Inc. (TSE:VRN – Get Free Report) traded up 16% during mid-day trading on Monday . The stock traded as high as C$8.39 and last traded at C$8.19. 27,269,131 shares traded hands during trading, an increase of 486% from the average session volume of 4,652,672 shares. The stock had previously closed at C$7.06.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on the company. National Bankshares lifted their target price on Veren from C$12.50 to C$13.00 and gave the stock an “outperform” rating in a research report on Thursday, January 30th. CIBC reduced their price target on shares of Veren from C$13.00 to C$12.50 in a research report on Friday, January 17th. Six equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Veren currently has a consensus rating of “Buy” and a consensus price target of C$11.83.
Check Out Our Latest Analysis on VRN
Veren Price Performance
Veren Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.115 per share. The ex-dividend date is Friday, March 14th. This represents a $0.46 annualized dividend and a yield of 5.62%.
About Veren
Veren Inc explores, develops, and produces oil and gas properties in Canada and the United States. The company focuses on crude oil, tight oil, natural gas liquids, shale gas, and natural gas reserves. Its properties are located in the provinces of Saskatchewan, Alberta, British Columbia, and Manitoba; and the states of North Dakota.
Featured Articles
- Five stocks we like better than Veren
- Differences Between Momentum Investing and Long Term Investing
- How to Protect Your Portfolio When Inflation Is Rising
- Why is the Ex-Dividend Date Significant to Investors?
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- About the Markup Calculator
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Veren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veren and related companies with MarketBeat.com's FREE daily email newsletter.